The Native Antigen Company Ltd

The Native Antigen Company is one of the world’s leading suppliers of antigens used in antibody testing kits for research into emerging diseases.

In 2020, the University of Birmingham spin-out was one of the first companies to start production of the Covid-19 antigens. Its SARS-CoV-2 Neutralization Assay Development Kits were recognised by The Scientist – the leading publication for life science professionals – as a Top 10 Innovation.

The company also played a key role in supplying products to combat both the Zika and Dengue virus in 2016 and 2018.

In January the Kidlington-based company announced the expansion of its noroviruslike particle range, with the addition of six new reagents, including four which are unique to the market.